# Shuzhen Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shuzhen-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,811 |
| Field | Retinal Development and Disorders |
| h-index | 47 |
| i10-index | 224 |
| OpenAlex ID | https://openalex.org/A5074494657 |
| ORCID iD | https://orcid.org/0000-0003-3869-2463 |
| Works | 628 |

## Researcher papers

- [A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://scholariq.org/papers/a-trial-of-lopinavir-ritonavir-in-adults-hospitalized-with-severe-covid-19/)
- [Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/)
- [A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia](https://scholariq.org/papers/a-36-week-multicenter-randomized-double-blind-placebo-controlled-parallel-group/)
- [Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice](https://scholariq.org/papers/inactivation-of-a-novel-fgf23-regulator-fam20c-leads-to-hypophosphatemic-rickets/)

## Researcher topics

- [Retinal Development and Disorders](https://scholariq.org/topics/retinal-development-and-disorders/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Genomics and Phylogenetic Studies](https://scholariq.org/topics/genomics-and-phylogenetic-studies/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.